P Messa
Overview
Explore the profile of P Messa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mattinzoli D, Messa P, Corbelli A, Ikehata M, Zennaro C, Armelloni S, et al.
Eur Cell Mater
. 2012 Nov;
24:403-25.
PMID: 23160992
Despite recent research which more and more stresses the importance of osteocytes in regulating bone and systemic mineral metabolism, current molecular and functional knowledge of osteocyte properties are still incomplete,...
22.
Fabrizi F, Dixit V, Messa P, MARTIN P
J Viral Hepat
. 2012 Oct;
19(11):784-91.
PMID: 23043385
The efficacy and safety of antiviral therapy in patients with acute hepatitis C on long-term dialysis remains unclear, although a number of small clinical studies have been published addressing this...
23.
Armelloni S, Li M, Messa P, Rastaldi M
Int J Biochem Cell Biol
. 2012 Sep;
44(12):2272-7.
PMID: 23018105
In the renal glomerulus, podocytes envelop the external side of the capillary basement membrane with their intertwining ramifications, and ensure elimination of metabolic waste within the urine, while proteins and...
24.
Fabrizi F, Dixit V, Messa P
J Viral Hepat
. 2012 Aug;
19(9):601-7.
PMID: 22863263
Recent evidence has been accumulated showing that anti-HCV-positive serologic status is significantly associated with lower survival in dialysis populations, but the mechanisms underlying this negative relationship are still unclear. The...
25.
Fabrizi F, Dixit V, MARTIN P, Messa P
J Viral Hepat
. 2011 Nov;
18(12):871-6.
PMID: 22093033
It is well known that the seroconversion rate of patients following hepatitis B virus (HBV) vaccination is lower in uraemic than healthy subjects. A variety of inherited or acquired factors...
26.
Frazao J, Messa P, Mellotte G, Geiger H, Hagen E, Quarles L, et al.
Clin Nephrol
. 2011 Sep;
76(3):233-43.
PMID: 21888861
Aims: To evaluate the relationship between the severity of secondary hyperparathyroidism (SHPT) - defined in terms of baseline plasma intact parathyroid hormone (iPTH) level - and the magnitude of response...
27.
Fabrizi F, MARTIN P, Messa P
Acta Gastroenterol Belg
. 2011 Feb;
73(4):465-71.
PMID: 21299156
The most common cause of liver disease in patients with chronic kidney disease (CKD) remains infection by hepatitis B virus (HBV) and/or hepatitis C virus (HCV). The adverse effects of...
28.
Fabrizi F, Dixit V, MARTIN P, Messa P
Aliment Pharmacol Ther
. 2011 Feb;
33(7):815-21.
PMID: 21281319
Background: Patients on maintenance dialysis typically show a suboptimal immune response to hepatitis B virus vaccine compared with the non-uraemic population. A variety of inherited or acquired factors have been...
29.
Fabrizi F, Dixit V, MARTIN P, Messa P
J Viral Hepat
. 2010 Nov;
18(7):e263-9.
PMID: 21108701
The efficacy and safety of combined interferon (IFN) plus ribavirin in patients on long-term dialysis and chronic hepatitis C remains unclear, although a number of small clinical trials have addressed...
30.
Fabrizi F, Dixit V, Messa P, MARTIN P
J Viral Hepat
. 2010 Sep;
18(10):730-7.
PMID: 20819147
Chronic dialysis patients are at risk of contracting hepatitis B virus infection and have a diminished immune response to hepatitis B virus vaccine. Recent reports support intradermal administration of hepatitis...